Innovating Works

INNOTECH VISION

Desconocido
c4c: conect4children COllaborative Network for European Clinical Trials For Children INNOTECH VISION participó en un H2020 H2020-JTI-IMI2-2016-10-two-stage Paediatric medicines development is embedded in the European policy, legislation and in the work of the pharmaceutical industry but currentl...
2018-06-22 - 2025-04-30 | Financiado
OligoGpivotalCF: A pivotal phase IIb clinical trial of inhaled alginate oligosaccharide OligoG for cystic fibrosis INNOTECH VISION participó en un H2020 H2020-SC1-2016-2017 The objective of the current proposal is to advance the orphan drug OligoG CF-5/20 (OligoG) through a pivotal phase IIb clinical trial, to e...
2017-12-05 - 2022-12-31 | Financiado
HIT-CF: Personalised Treatment For Cystic Fibrosis Patients With Ultra rare CFTR Mutations and beyond INNOTECH VISION participó en un H2020 H2020-SC1-2016-2017 In our HIT-CF project, we aim to bring personalised disease modifying therapies to cystic fibrosis (CF) patients with ultra-rare CFTR mutati...
2017-11-28 - 2025-06-30 | Financiado
Farmers Pride: Networking partnerships and tools to enhance in situ conservation of European plant genetic resourc... INNOTECH VISION participó en un H2020 H2020-SFS-2016-2017 The overarching objective of Farmer’s Pride is to establish a network of stakeholders and conservation sites that effectively coordinates co...
2017-10-09 - 2021-07-31 | Financiado
PRO-CF-MED: Clinical Proof of concept for a RNA targeting Oligonucleotide for a Cystic fibrosis F508del MEDicati... INNOTECH VISION participó en un H2020 H2020-PHC-2014-2015 Cystic fibrosis (CF) is a progressive life-shortening disease caused by a mutation in the cystic fibrosis transmembrane conductance regulato...
2015-04-21 - 2017-12-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.